Friday, 1 May 2020
U.S. emergency approval broadens use of Gilead’s COVID-19 drug remdesivir
By Steve Holland WASHINGTON (Reuters) - Gilead Science Inc's antiviral drug remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration for COVID-19 on Friday, clearing the way for broader use of the drug in more hospitals around the United States
The post U.S. emergency approval broadens use of Gilead’s COVID-19 drug remdesivir appeared first on Firstpost.
from Firstpost https://ift.tt/3faHQYk
Subscribe to:
Post Comments
(
Atom
)
No comments :
Post a Comment